Drug Profile
PD 142898
Latest Information Update: 24 Jan 2007
Price :
$50
*
At a glance
- Originator Pfizer
- Class Analgesics; Anxiolytics; Indoles
- Mechanism of Action Cholecystokinin A receptor antagonists; Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Pain
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Anxiety disorders in United Kingdom (Unknown route)
- 31 Aug 1998 No-Development-Reported for Pain in United Kingdom (Unknown route)
- 17 Sep 1996 Preclinical development for Pain in United Kingdom (Unknown route)